Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kefir for prevention of C. difficile-associated diarrhea
NCT02707198Phase 2Terminated
- Sponsor
- St. Luke's Duluth
- Start
- Nov 2015
- Primary completion
- May 2019
01
Overview
Phase 2, randomised, open-label trial in Clostridium difficile infection (CDI) and diarrhea (3 arms), sponsored by St. Luke's Duluth. Primary endpoint: Incidence of Diarrhea Among the Three Randomized Study Groups Over Time. Started Nov 2015; status: terminated.
02
Conditions
Clostridium difficile infection (CDI)diarrhea
Beyond the preview
Go deeper on NCT02707198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707198.